Ocular Therapeutix: TD Cowen Maintains Buy Rating with $20 PT

jueves, 30 de octubre de 2025, 4:16 pm ET1 min de lectura
OCUL--

Ocular Therapeutix: TD Cowen Maintains Buy Rating with $20 PT

Ocular Therapeutix: TD Cowen Maintains Buy Rating with $20 PT

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios